These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9796656)
1. Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies. Bello PY; Pasquier C; Gourney P; Puel J; Izopet J Eur J Clin Microbiol Infect Dis; 1998 Aug; 17(8):570-2. PubMed ID: 9796656 [TBL] [Abstract][Full Text] [Related]
2. [Detection of hepatitis C virus antibody in saliva and its clinical significance]. Zhou D; Yang Z; Wang L; Fu Y Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):449-51. PubMed ID: 12641961 [TBL] [Abstract][Full Text] [Related]
3. The use of oral fluid for hepatitis C antibody screening. Sherman KE; Creager RL; O'Brien J; Sargent S; Piacentini S; Thieme T Am J Gastroenterol; 1994 Nov; 89(11):2025-7. PubMed ID: 7524312 [TBL] [Abstract][Full Text] [Related]
4. Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies. Amado LA; Villar LM; de Paula VS; de Almeida AJ; Gaspar AM Mem Inst Oswaldo Cruz; 2006 Mar; 101(2):149-55. PubMed ID: 16830707 [TBL] [Abstract][Full Text] [Related]
5. Correlation between detection of antibodies against hepatitis C virus in oral fluid and hepatitis C virus RNA in serum. Cock De L; Hutse V; Vranckx R Eur J Clin Microbiol Infect Dis; 2005 Aug; 24(8):566-8. PubMed ID: 16133413 [TBL] [Abstract][Full Text] [Related]
6. Detection of HCV antibodies in oral fluid. De Cock L; Hutse V; Verhaegen E; Quoilin S; Vandenberghe H; Vranckx R J Virol Methods; 2004 Dec; 122(2):179-83. PubMed ID: 15542142 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of hepatitis C antibody testing in saliva specimens collected by two different systems in comparison with HCV antibody and HCV RNA in serum. van Doornum GJ; Lodder A; Buimer M; van Ameijden EJ; Bruisten S J Med Virol; 2001 May; 64(1):13-20. PubMed ID: 11285563 [TBL] [Abstract][Full Text] [Related]
8. Comparison between self-reported hepatitis B, hepatitis C, and HIV antibody status and oral fluid assay results in Irish prisoners. Thornton L; Barry J; Long J; Allwright S; Bradley F; Parry JV Commun Dis Public Health; 2000 Dec; 3(4):253-5. PubMed ID: 11280253 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. Judd A; Parry J; Hickman M; McDonald T; Jordan L; Lewis K; Contreras M; Dusheiko G; Foster G; Gill N; Kemp K; Main J; Murray-Lyon I; Nelson M J Med Virol; 2003 Sep; 71(1):49-55. PubMed ID: 12858408 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro. Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort). Quaranta JF; Delaney SR; Alleman S; Cassuto JP; Dellamonica P; Allain JP J Med Virol; 1994 Jan; 42(1):29-32. PubMed ID: 7508489 [TBL] [Abstract][Full Text] [Related]
12. Low risk of sexual transmission of hepatitis C virus in Somalia. Watts DM; Corwin AL; Omar MA; Hyams KC Trans R Soc Trop Med Hyg; 1994; 88(1):55-6. PubMed ID: 8154002 [TBL] [Abstract][Full Text] [Related]
13. Salivary HCV-antibodies; a follow-up cohort study of liver disease patients. Elsana S; Sikuler E; Yaari A; Shemer-Avni Y; Margalith M Clin Lab; 2001; 47(7-8):335-8. PubMed ID: 11499794 [TBL] [Abstract][Full Text] [Related]
14. An evaluation of saliva as an alternative to plasma for the detection of hepatitis C virus antibodies. Moorthy M; Daniel HD; Kurian G; Abraham P Indian J Med Microbiol; 2008; 26(4):327-32. PubMed ID: 18974484 [TBL] [Abstract][Full Text] [Related]
15. A method for the detection and confirmation of antibodies to hepatitis C virus in dried blood spots. Parker SP; Cubitt WD; Ades AE J Virol Methods; 1997 Nov; 68(2):199-205. PubMed ID: 9389410 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease. Leslie DE; Rann S; Nicholson S; Fairley CK; Gust ID Med J Aust; 1992 Jun; 156(11):789-92. PubMed ID: 1321326 [TBL] [Abstract][Full Text] [Related]
18. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites. Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221 [TBL] [Abstract][Full Text] [Related]
19. Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection. Visseaux B; Larrouy L; Calin R; Katlama C; Poynard T; Ratziu V; Thibault V J Clin Virol; 2013 Oct; 58(2):385-90. PubMed ID: 23953940 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population. Rapicetta M; Attili AF; Mele A; De Santis A; Chionne P; Cristiano K; Spada E; Giuliani E; Carli L; Goffredo F J Med Virol; 1992 Jun; 37(2):87-92. PubMed ID: 1378484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]